Ilion Medical, Inc.
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Ilion ranks #40,856 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.
- #40,856
- of 49,997 US assignees by volume
- 12th percentile
- by Innovation Score (23.4/100)
- 17.5
- avg claims per patent
- -80%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R40856 · US Corporation #40,856 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #40,856/49,997
- PHOTO-FINISH Ideal Life
- CPC-NARROW A61B · 3 areas
- INNOV-THIN 23.4/100
- CLAIMS-RICH 17.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -80% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Ideal Life Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ilion’s 23.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ilion
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ilion Medical · this assignee 23
Ilion Medical · this assignee
23 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ilion's Innovation Score is 23.4/100 (12th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ilion?
Each dot is one of Ilion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ilion’s own 17.5 claims/patent is ABOVE the 11.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Ilion's grants concentrate
Ilion Medical, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 83.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2018. By volume, Ilion sits between Ideal Life Inc. and Impossible Diamond, Inc..
Who files at Ilion's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Ideal Life
Ideal Life Inc.
6 patents
- Ideal Living
Ideal Living, LLC
6 patents
- Idesyn Semiconduc…
Idesyn Semiconductor Corp.
6 patents
- Ignition Interfac…
Ignition Interfaces, Inc.
6 patents
- Illinois Grain &…
Illinois Grain & Seed, Inc.
6 patents
- Immunsys
ImmunSys, Inc.
6 patents
- Imnate Sarl
Imnate Sarl
6 patents
- Impossible Diamond
Impossible Diamond, Inc.
6 patents
- Ilion Medical ◀
Ilion Medical, Inc.
6 patents
What this shows Ilion holds 6 patents at rank #40,955, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ilion
By rank, the assignees closest to #40,955 in granted patent volume.
- Ideal Life Inc. #40,951 · 6 patents
- Ideal Living, LLC #40,952 · 6 patents
- Idesyn Semiconductor Corp. #40,953 · 6 patents
- Ignition Interfaces, Inc. #40,954 · 6 patents
- Illinois Grain & Seed, Inc. #40,956 · 6 patents
- ImmunSys, Inc. #40,957 · 6 patents
- Imnate Sarl #40,958 · 6 patents
- Impossible Diamond, Inc. #40,959 · 6 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Ilion's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Ilion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
23 12th percentile higher than 12% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 33.3% |
| 2017 | 2 | 33.3% |
| 2018 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
Which technologies does Ilion Medical, Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ilion Medical, Inc.'s patent record in context - here's where to go next.
- Ilion Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 83.3% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #40,856 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ilion Medical, Inc. against Ideal Life Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 23.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.